Audit Dispute. In the event of a dispute with respect to any audit under [Section 5.9.1] (Audit), ARScience Bio and Coya shall work in good faith to resolve such dispute. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within 30 days, then the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than 30 days after such decision and in accordance with such decision, Coya shall pay the additional amounts, with interest from the date originally due as provided in Section 5.12 (Overdue Payments), or ARScience Bio shall reimburse the excess payments, as applicable.

Audit Dispute. In the event of a dispute with respect to any audit under [Section 4.10] (Audit), [[AstraZeneca:Organization]] and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within ​ days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Auditor”). ​.

Audit Dispute. In the event of a dispute with respect to any audit under [Section 8.12, REGENX and PARTNER]R] shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within ​, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Auditor”). The decision of the Auditor shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Auditor shall determine. Not later than ​ after such decision and in accordance with such decision, the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 8.10, or the auditing Party shall reimburse the excess payments, as applicable.

Audit Dispute. If Everest disputes the results of any audit conducted pursuant to [Section 8.9] (Financial Records and Audit), the Parties shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within ​ Business Days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Auditor”). The decision of the Auditor shall be final and the costs of such procedure as well as the initial audit shall be borne between Portions of the exhibit, indicated by the mark “​,” were omitted and have been filed separately with the

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.10, [[AstraZeneca:Organization]] and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within 30 days, the dispute shall be submitted for resolution to a qualified, independent certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Resolution Auditor”). The decision of the Resolution Auditor shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Resolution Auditor shall determine. Not later than 10 days after such decision and in accordance with such decision, Licensee shall pay the additional amounts or [[AstraZeneca:Organization]] shall reimburse the excess payments, as applicable.

Audit Dispute. In the event of a dispute with respect to any audit under [Section 7.9.1], the Parties shall work in good faith to resolve the dispute. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within ​, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

Audit Dispute. In the event of a dispute with respect to any audit under [Section 8.11(b)], FibroGen China and AstraZeneca shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within thirty (30) days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other entity or individual as the Parties shall mutually agree (the “Auditor”). The decision of the Auditor shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Auditor shall determine. Not later than ten (10) days after such decision and in accordance with such decision, the audited Party shall pay the additional amounts, with interest from the date originally due as provided in [Section 8.10] or the auditing Party shall reimburse the excess payments, as applicable.

Audit Dispute. In the event of a dispute over the results of any audit conducted pursuant to [Section 6.7], [[Sanofi:Organization]] and Acer shall work in good faith to resolve such dispute. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within thirty (30) calendar days, the dispute shall be submitted for arbitration to a certified public accounting firm selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Accountant”) or failing such agreement, as the Chairman of the International Chamber of Commerce (or such other body as the Parties may mutually agree), may nominate. The decision of the Accountant shall be final. The Parties shall share equally the costs of such arbitration. Not later than thirty (30) calendar days after such decision and in accordance with such decision, Acer shall pay any additional royalties, with interest from the date originally due as provided in [Section 6.5] or [[Sanofi:Organization]] shall reimburse such excess payments, as applicable.

Audit Dispute. In the event of a dispute with respect to any audit under [Section 5.7], the Parties shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within thirty (30) days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Accountant”). The Parties shall enter into an engagement letter with the Accountant, which shall spell out the specific procedures that the Accountant shall perform in order to reach a decision. The Parties shall make available to the Accountant all working papers and supporting documents required by the Accountant to fulfill its obligations under the engagement letter. The decision of the Accountant shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Accountant shall determine. Not later than ten (10) days after such decision and in accordance with such decision, the audited Party shall pay the additional amounts, with interest as provided in [Section 5.5], or the auditing Party shall reimburse such excess payments, as applicable.

Audit Dispute. In the event of a dispute with respect to any audit under [Section 7.13], Licensor and [[Organization A:Organization]] shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within ​, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than ​ after such decision and in accordance with such decision, [[Organization A:Organization]] shall pay the additional amounts, with interest from the date originally due as provided in [Section 7.10], or Licensor shall reimburse the excess payments, as applicable.